Form 4: Serina Therapeutics Director Gregory Bailey Acquires Additional Shares
SEC Form 4
Director Gregory Bailey of Serina Therapeutics, Inc. recently purchased 1,776 shares of common stock at an average price of $8.25.
Summary
- On August 20, 2024, Gregory Bailey, a director of Serina Therapeutics, Inc. (SER), acquired 1,776 shares of common stock.
- The purchase was made at a weighted average price of $8.25 per share, with individual transactions ranging from $8.00 to $8.88 per share.
- Following the transaction, Bailey directly owns 47,582 shares of Serina Therapeutics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but the amount is relatively small and doesn't provide a strong signal.
Positives
- The director's purchase could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases are generally seen as positive signals.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of stock purchase transaction |
| 08/22/2024 | Date of signature on the SEC Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.